You are here

  • Home
  • Archive
  • Volume 9, Issue 5
  • Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study

Article metrics

Article menu
XML
Immunotherapy biomarkers
Original research
Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study

 

Online download statistics by month:

Online download statistics by month: May 2021 to March 2024

AbstractFullPdf
May 2021665666158
Jun 202119319351
Jul 202116016056
Aug 202111811833
Sep 2021888823
Oct 202111011040
Nov 2021969630
Dec 2021858524
Jan 2022778028
Feb 2022485019
Mar 2022767634
Apr 2022717316
May 2022697026
Jun 2022666917
Jul 2022545414
Aug 2022595922
Sep 2022848618
Oct 2022525420
Nov 2022323211
Dec 2022373716
Jan 202339398
Feb 202367678
Mar 2023353618
Apr 2023333411
May 2023384016
Jun 2023424212
Jul 2023484815
Aug 2023393914
Sep 202324246
Oct 2023333317
Nov 2023717211
Dec 202312512714
Jan 2024384121
Feb 2024474714
Mar 2024343446
Total29532979887